Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nasdaq Inc (NDAQ) vs Sanofi SA (SNY) Price & Performance

Nasdaq IncTrade
Sanofi SATrade

Price performance (Past 24H)

Key statistics

Nasdaq Inc vs Sanofi SA — how do they compare? Nasdaq Inc trades at $90.25 (market cap $51.96B), while Sanofi SA trades at $44.05 (market cap $104.83B). The key difference: Sanofi SA is far larger — about 2× Nasdaq Inc's market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.

NDAQSNY
Market Cap
$51.96B$104.83B
Sector
FinancialsHealth
52-Week High
$100.98$52.34
52-Week Low
$76.85$41.33
Enterprise Value
$59.02B$121.32B
Dividend Yield
1.22%5.5%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Nasdaq Inc

Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.

Read more on NDAQ

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY